clinical trial · NCT02781922
Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)
Metcela Inc.·phase3·recruiting·n = 40
Hypoplastic Left Heart SyndromeSingle VentricleAutologous cardiac stem cells (JRM-001)
brief summary
The purpose of this study is to evaluate the efficacy and safety of intracoronary injection of JRM-001 after reconstructive surgery in pediatric patients with functional single ventricle
started
Jun 1, 2016
primary completion
Dec 1, 2028
completion
Dec 1, 2028
last updated
Sep 30, 2025
official title
Efficacy and Safety Study of Autologous Cardiac Stem Cells (JRM-001) Treated After Reconstructive Surgery in Pediatric Patients With Congenital Heart Disease: A Multicenter Randomized Single-blind Parallel-group Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol